Commonwealth of Pennsylvania Public School Empls Retrmt SYS Buys 21,925 Shares of CVS Health Corporation $CVS

Commonwealth of Pennsylvania Public School Empls Retrmt SYS increased its stake in shares of CVS Health Corporation (NYSE:CVS) by 7.6% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 310,253 shares of the pharmacy operator’s stock after buying an additional 21,925 shares during the quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS’s holdings in CVS Health were worth $21,401,000 at the end of the most recent reporting period.

A number of other large investors have also recently bought and sold shares of CVS. Avion Wealth increased its position in CVS Health by 99.0% in the 2nd quarter. Avion Wealth now owns 380 shares of the pharmacy operator’s stock valued at $26,000 after acquiring an additional 189 shares in the last quarter. Harbor Asset Planning Inc. bought a new stake in shares of CVS Health during the second quarter valued at approximately $30,000. Bell Investment Advisors Inc increased its holdings in shares of CVS Health by 119.8% in the first quarter. Bell Investment Advisors Inc now owns 455 shares of the pharmacy operator’s stock valued at $31,000 after purchasing an additional 248 shares in the last quarter. Roxbury Financial LLC raised its position in CVS Health by 78.3% in the 2nd quarter. Roxbury Financial LLC now owns 460 shares of the pharmacy operator’s stock worth $32,000 after purchasing an additional 202 shares during the last quarter. Finally, ORG Partners LLC lifted its holdings in CVS Health by 418.9% during the 2nd quarter. ORG Partners LLC now owns 467 shares of the pharmacy operator’s stock worth $32,000 after buying an additional 377 shares in the last quarter. 80.66% of the stock is currently owned by institutional investors.

CVS Health Trading Down 1.7%

Shares of NYSE CVS opened at $77.86 on Friday. CVS Health Corporation has a twelve month low of $43.56 and a twelve month high of $85.15. The stock has a market cap of $98.84 billion, a price-to-earnings ratio of 204.90, a P/E/G ratio of 0.87 and a beta of 0.60. The company has a quick ratio of 0.62, a current ratio of 0.83 and a debt-to-equity ratio of 0.83. The company’s fifty day moving average is $77.70 and its 200-day moving average is $69.93.

CVS Health (NYSE:CVS) last issued its quarterly earnings data on Wednesday, October 29th. The pharmacy operator reported $1.60 EPS for the quarter, topping the consensus estimate of $1.36 by $0.24. The business had revenue of $102.87 billion for the quarter, compared to the consensus estimate of $98.85 billion. CVS Health had a return on equity of 11.45% and a net margin of 0.12%.The firm’s revenue was up 7.8% compared to the same quarter last year. During the same quarter last year, the business posted $1.09 EPS. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS. Equities research analysts predict that CVS Health Corporation will post 5.89 EPS for the current year.

CVS Health Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Monday, November 3rd. Stockholders of record on Thursday, October 23rd were issued a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a dividend yield of 3.4%. The ex-dividend date was Thursday, October 23rd. CVS Health’s payout ratio is 700.00%.

Insider Activity

In related news, Director Anne A. Finucane sold 7,500 shares of the stock in a transaction that occurred on Wednesday, August 20th. The stock was sold at an average price of $71.02, for a total transaction of $532,650.00. Following the completion of the sale, the director directly owned 22,156 shares of the company’s stock, valued at approximately $1,573,519.12. This represents a 25.29% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Corporate insiders own 1.22% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently commented on CVS shares. Wolfe Research lifted their target price on CVS Health from $80.00 to $85.00 and gave the company an “outperform” rating in a research note on Monday, September 22nd. Evercore ISI lifted their price objective on CVS Health from $85.00 to $95.00 and gave the stock an “outperform” rating in a research report on Thursday, October 30th. Baird R W upgraded shares of CVS Health from a “hold” rating to a “strong-buy” rating in a research report on Thursday, August 14th. Wall Street Zen lowered shares of CVS Health from a “buy” rating to a “hold” rating in a research note on Saturday, November 1st. Finally, Cantor Fitzgerald boosted their price target on shares of CVS Health from $78.00 to $95.00 and gave the stock an “overweight” rating in a research note on Thursday, October 30th. Two analysts have rated the stock with a Strong Buy rating, twenty-one have issued a Buy rating and four have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $89.41.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.